Analyst Consensus ?
ConsensusBuy44 ratings
Bullish2863.6%
Neutral1636.4%
Bearish00.0%
FN2 Earnings Intelligence
Johnson Controls International plc (JCI) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 9, 2026 |
| UBS | Buy | Buy | Maintain | Jun 2, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jun 2, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | May 7, 2026 |
| Mizuho | Neutral | Neutral | Maintain | May 7, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 7, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 7, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 6, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 7, 2025 |
| Argus Research | Buy | Buy | Maintain | Nov 7, 2025 |
| Jefferies | Hold | Buy | Downgrade | Jul 24, 2025 |
| Baird | Neutral | Neutral | Maintain | Jul 17, 2025 |
| Oppenheimer | Perform | Outperform | Downgrade | Jun 20, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | May 12, 2025 |
| Melius Research | Hold | Buy | Downgrade | Jan 28, 2025 |
| B of A Securities | Buy | Buy | Maintain | Sep 27, 2024 |
| HSBC | Hold | Buy | Downgrade | Jan 31, 2024 |
| Vertical Research | Hold | Buy | Downgrade | Dec 13, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 4, 2022 |
| OTR Global | Positive | Mixed | Upgrade | Apr 27, 2021 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Dec 9, 2020 |
| CFRA | Buy | Buy | Maintain | May 1, 2020 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 9, 2020 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Feb 19, 2019 |
| Argus | Buy | Hold | Upgrade | Aug 21, 2018 |
| Susquehanna | Neutral | Positive | Downgrade | Nov 15, 2017 |
| Vertical Group | Hold | Buy | Downgrade | Nov 10, 2017 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 23, 2017 |
| Bernstein | Outperform | Outperform | Maintain | Sep 16, 2016 |
| Macquarie | Outperform | Outperform | Maintain | Sep 8, 2016 |
| William Blair | Market Perform | Outperform | Downgrade | Dec 2, 2015 |
| Nomura | Buy | Buy | Maintain | Oct 2, 2015 |
| Ascendiant Capital | Buy | Buy | Maintain | Dec 23, 2014 |
| FBR Capital | Outperform | Outperform | Maintain | Feb 19, 2014 |
| Lazard | Buy | Neutral | Upgrade | May 13, 2013 |
| Credit Agricole | Buy | Outperform | Maintain | Mar 14, 2013 |
| Stifel Nicolaus | Buy | Buy | Maintain | Nov 1, 2012 |
| Stifel | Buy | Buy | Maintain | Nov 1, 2012 |
| Needham | Hold | Buy | Downgrade | Nov 1, 2012 |
| Sterne Agee | Neutral | Neutral | Maintain | Jul 24, 2012 |
| Bank of America | Buy | Buy | Maintain | Jul 19, 2012 |
| Wunderlich Securities | Buy | Buy | Maintain | Jul 6, 2012 |
| Wunderlich | Buy | Buy | Maintain | Jul 6, 2012 |
| Guggenheim | Buy | Buy | Maintain | Mar 7, 2012 |
Upside is calculated against the persisted previous close $140.28. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Bernstein | Analyst unavailable | $176 | $147.75 | +25.5% | Jun 9, 2026 |
| Morgan Stanley | Chris Snyder | $175 | $144.05 | +24.8% | Jun 9, 2026 |
| Wolfe Research | Analyst unavailable | $171 | $141.99 | +21.9% | Jun 3, 2026 |
| UBS | Amit Mehrotra | $180 | $141.26 | +28.3% | Jun 2, 2026 |
| RBC Capital | Analyst unavailable | $154 | $139.12 | +9.8% | May 7, 2026 |
| Barclays | Julian Mitchell | $144 | $143.14 | +2.7% | May 7, 2026 |
| Morgan Stanley | Christopher Snyder | $140 | $134.99 | -0.2% | Mar 11, 2026 |
| RBC Capital | Deane Dray | $140 | $131.97 | -0.2% | Feb 5, 2026 |
| Mizuho Securities | Analyst unavailable | $130 | $131.39 | -7.3% | Feb 5, 2026 |
| Goldman Sachs | Analyst unavailable | $154 | $129.49 | +9.8% | Feb 5, 2026 |
| Robert W. Baird | Analyst unavailable | $132 | $129.49 | -5.9% | Feb 5, 2026 |
| Barclays | Analyst unavailable | $136 | $129.49 | -3.1% | Feb 5, 2026 |
| Morgan Stanley | Analyst unavailable | $130 | $111.51 | -7.3% | Jan 13, 2026 |
| Melius Research | Scott Davis | $148 | $113.95 | +5.5% | Jan 7, 2026 |
| Barclays | Analyst unavailable | $125 | $113.95 | -10.9% | Jan 7, 2026 |
| Goldman Sachs | Analyst unavailable | $142 | $122.25 | +1.2% | Nov 6, 2025 |
| UBS | Amit Mehrotra | $124 | $123 | -11.6% | Nov 6, 2025 |
| Barclays | Julian Mitchell | $90 | $95.28 | -35.8% | May 14, 2025 |
| Wells Fargo | Joe O’Dea | $100 | $91.68 | -28.7% | May 8, 2025 |
| Barclays | Analyst unavailable | $85 | $80.07 | -39.4% | Mar 10, 2025 |
| Wells Fargo | Joesph O'Dea | $92 | $79.17 | -34.4% | Jan 7, 2025 |
| Argus Research | John Eade | $88 | $79.25 | -37.3% | Dec 20, 2024 |
| Bank of America Securities | Andrew Obin | $80 | $68.6 | -43.0% | Sep 10, 2024 |
| Morgan Stanley | Chris Snyder | $85 | $69.38 | -39.4% | Sep 6, 2024 |
| RBC Capital | Sector Perform | $69 | $67.82 | -50.8% | Aug 14, 2024 |
| RBC Capital | Deane Dray | $61 | $71.03 | -56.5% | Aug 1, 2024 |
| Barclays | Julian Mitchell | $62 | $68.19 | -55.8% | Jun 21, 2024 |
| Barclays | Julian Mitchell | $61 | $65.13 | -56.5% | Apr 2, 2024 |
| RBC Capital | Deane Dray | $67 | $56.08 | -52.2% | Dec 11, 2023 |
| Morgan Stanley | Joshua Pokrzywinski | $73 | $58.51 | -48.0% | May 5, 2023 |
| Oppenheimer | Analyst unavailable | $72 | $66.36 | -48.7% | Feb 2, 2023 |
| Wells Fargo | Analyst unavailable | $72 | $65.02 | -48.7% | Jan 5, 2023 |
| Barclays | Analyst unavailable | $75 | $65.65 | -46.5% | Jan 5, 2023 |
| Citigroup | Analyst unavailable | $68 | $65.77 | -51.5% | Dec 9, 2022 |
| Deutsche Bank | Analyst unavailable | $74 | $66.98 | -47.2% | Dec 5, 2022 |
| J.P. Morgan | Analyst unavailable | $70 | $67.63 | -50.1% | Dec 2, 2022 |
| Morgan Stanley | Analyst unavailable | $62 | $54.89 | -55.8% | Sep 1, 2022 |
| Morgan Stanley | Analyst unavailable | $61 | $55.53 | -56.5% | Aug 8, 2022 |
| Oppenheimer | Analyst unavailable | $63 | $55.1 | -55.1% | Aug 8, 2022 |
| Jefferies | Stephen Volkmann | $65 | $50.34 | -53.7% | Jul 26, 2022 |
| Mizuho Securities | Analyst unavailable | $65 | $47.03 | -53.7% | Jul 18, 2022 |
| Barclays | Analyst unavailable | $60 | $47.67 | -57.2% | Jul 8, 2022 |
| Morgan Stanley | Analyst unavailable | $54 | $47.82 | -61.5% | Jul 7, 2022 |
| Wells Fargo | Analyst unavailable | $60 | $48.44 | -57.2% | Jun 29, 2022 |
| Goldman Sachs | Analyst unavailable | $62 | $47.44 | -55.8% | Jun 23, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $59 | $55 | -57.9% | Jun 7, 2022 |
| Barclays | Analyst unavailable | $65 | $50.89 | -53.7% | May 24, 2022 |
| RBC Capital | Analyst unavailable | $61 | $54.59 | -56.5% | May 5, 2022 |
| Credit Suisse | John Walsh | $73 | $54.83 | -48.0% | May 5, 2022 |
| Morgan Stanley | Analyst unavailable | $71 | $54.84 | -49.4% | May 5, 2022 |
| Barclays | Julian Mitchell | $80 | $66.2 | -43.0% | Apr 5, 2022 |
| Deutsche Bank | Nicole DeBlase | $80 | $68.88 | -43.0% | Feb 3, 2022 |
| Jefferies | Stephen Volkmann | $90 | $73.39 | -35.8% | Jan 24, 2022 |
| Cowen & Co. | Gautam Khanna | $86 | $80.87 | -38.7% | Dec 31, 2021 |
| UBS | Markus Mittermaier | $92 | $77.03 | -34.4% | Dec 14, 2021 |
| Citigroup | Andrew Kaplowitz | $81 | $73.75 | -42.3% | Nov 8, 2021 |
| Oppenheimer | Noah Kaye | $86 | $74.62 | -38.7% | Sep 9, 2021 |
| HSBC | Puneet Garg | $66 | $70.41 | -53.0% | Aug 4, 2021 |
| Wolfe Research | Nigel Coe | $83 | $69.75 | -40.8% | Jul 12, 2021 |
| Goldman Sachs | Joe Ritchie | $83 | $67.72 | -40.8% | Jun 30, 2021 |
| Argus Research | John Eade | $72 | $63.75 | -48.7% | May 6, 2021 |
Track every rating change on JCI the moment it posts. Free to start.
Start free